ID

15179

Beschreibung

International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia. Phase 3 Study. Study Protocol IB (Study Protocol IB with PEG-L-ASP). Clinical Trial Number: NCT01117441.

Stichworte

Versionen (1)
  1. 21.05.16 21.05.16 -
Hochgeladen am

21. Mai 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC-ND 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Protocol IB-ASP+ AIEOP-BFM ALL 2009 DRKS00003772 NCT01117441

Englisch

Protocol IB-ASP+ AIEOP-BFM ALL 2009 NCT01117441

1 Formulare  
Patient Information
Beschreibung

Patient Information

Alias
UMLS CUI-1
C1955348
Stud.-Nr. (Pat.-ID)
Beschreibung

Patient ID

Datentyp

text

Alias
UMLS CUI [1]
C2348585
Patient date of birth
Beschreibung

Patient birthday

Datentyp

date

Alias
UMLS CUI [1]
C0421451
Body weight
Beschreibung

Weight

Datentyp

float

Maßeinheiten
  • kg
Alias
UMLS CUI [1]
C0005910
kg
Body height
Beschreibung

Height

Datentyp

float

Maßeinheiten
  • cm
Alias
UMLS CUI [1]
C0005890
cm
Body surface
Beschreibung

Body surface

Datentyp

float

Maßeinheiten
  • mˆ2
Alias
UMLS CUI [1]
C0005902
mˆ2
Chemotherapy Regimen
Beschreibung

Chemotherapy Regimen

Alias
UMLS CUI-1
C0392920
Dexamethasone administration form
Beschreibung

Dexamethasone: administration form

Datentyp

text

Alias
UMLS CUI [1,1]
C0011777
UMLS CUI [1,2]
C0013153
Dexamethasone dosage 10 mg/mˆ2/d
Beschreibung

Dexamethasone: dosage

Datentyp

float

Maßeinheiten
  • mg
Alias
UMLS CUI [1,1]
C0011777
UMLS CUI [1,2]
C0178602
mg
Dexamethasone Date of administration
Beschreibung

Dexamethasone: date of administration

Datentyp

date

Alias
UMLS CUI [1,1]
C0011777
UMLS CUI [1,2]
C2584899
VCR administration form i.v.
Beschreibung

VCR: administration form

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0042679
UMLS CUI [1,2]
C1522726
VCR dosage 1,5 mg/mˆ2/ED (max. 2 mg/ED)
Beschreibung

VCR: dosage

Datentyp

float

Maßeinheiten
  • mg
Alias
UMLS CUI [1,1]
C0042679
UMLS CUI [1,2]
C0178602
mg
VCR Date of administration
Beschreibung

VCR: date of administration

Datentyp

date

Alias
UMLS CUI [1,1]
C0042679
UMLS CUI [1,2]
C2584899
Doxorubicin administration form p.i. (1h)
Beschreibung

DOX: administration form

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013089
UMLS CUI [1,2]
C1827465
Doxorubicin dosage 30 mg/mˆ2/ED
Beschreibung

DOX: dosage

Datentyp

float

Maßeinheiten
  • mg
Alias
UMLS CUI [1,1]
C0013089
UMLS CUI [1,2]
C0178602
mg
Doxorubicin Date of administration
Beschreibung

DOX: date of administration

Datentyp

date

Alias
UMLS CUI [1,1]
C0013089
UMLS CUI [1,2]
C2584899
MTX administration form i.th
Beschreibung

MTX: administration form

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0677897
MTX dosage (Age-dependent: 1 - < 2 y/o: 8 mg 2 - < 3y/o: 10 mg >= 3 y/o: 12 mg
Beschreibung

MTX: dosage

Datentyp

float

Maßeinheiten
  • mg
Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
mg
MTX Date of administration (while MTX infusion)
Beschreibung

MTX: date of administration

Datentyp

date

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C2584899
If initial CNS status CNS3, MTX dose (i.th., on day 1 and 18): Date of administration
Beschreibung

MTX and CNS status: date of administration

Datentyp

date

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0449389
UMLS CUI [1,3]
C2584899
PEG-L-ASP administration form p.i. (2h)
Beschreibung

PEG-L-ASP: administration form

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C1827465
PEG-L-ASP dosage 2500 E/mˆ2/ED (ONCASPAR: 3750 E/ED)
Beschreibung

PEG-L-ASP: dosage

Datentyp

float

Maßeinheiten
  • E
Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C0178602
E
PEG-L-ASP (Next PEG-L-ASP dose: 14 days after dose of day 22)) Date of administration
Beschreibung

PEG-L-ASP: date of administration

Datentyp

date

Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C2584899
PEG-L-ASP discontinuation
Beschreibung

PEG-L-ASP discontinuation

Alias
UMLS CUI-1
C0071568
UMLS CUI-2
C0457454
Discontinuation of PEG-L-ASP therapy in Protocol IIA-ASP+?
Beschreibung

PEG-L-ASP discontinuation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C0457454
If discontinuation of PEG-L-ASP therapy, specify: Reason for discontinuation:
Beschreibung

Reason for discontinuation of PEG-L-ASP therapy

Datentyp

text

Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C0457454
UMLS CUI [1,3]
C0392360
If discontinuation of PEG-L-ASP therapy, specify: Reason for discontinuation: If other medical or non-medical reason, specify:
Beschreibung

Reason for discontinuation of PEG-L-ASP therapy: specification

Datentyp

text

Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C0457454
UMLS CUI [1,3]
C0392360
UMLS CUI [1,4]
C2348235
If discontinuation of PEG-L-ASP therapy, specify: PEG-L-ASP: date of last administration
Beschreibung

PEG-L-ASP: date of last administration

Datentyp

text

Alias
UMLS CUI [1,1]
C0071568
UMLS CUI [1,2]
C2584899
UMLS CUI [1,3]
C1517741
Change to Erwinase?
Beschreibung

Change to Erwinase

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0580105
UMLS CUI [1,2]
C0591457
If change to Erwinase, specify: Erwinase: date of first administration
Beschreibung

Erwinase: date of first administration

Datentyp

date

Alias
UMLS CUI [1,1]
C0591457
UMLS CUI [1,2]
C2584899
UMLS CUI [1,3]
C0205435
If change to Erwinase, specify: Erwinase: date of last administration
Beschreibung

Erwinase: date of last administration

Datentyp

date

Alias
UMLS CUI [1,1]
C0591457
UMLS CUI [1,2]
C2584899
UMLS CUI [1,3]
C1517741
If change to Erwinase, specify: Numbers of Erwinase doses
Beschreibung

Numbers of Erwinase doses

Datentyp

float

Alias
UMLS CUI [1,1]
C0591457
UMLS CUI [1,2]
C0237753
If change to Erwinase, specify: Erwinase dose
Beschreibung

Erwinase dose

Datentyp

float

Maßeinheiten
  • E
Alias
UMLS CUI [1,1]
C0591457
UMLS CUI [1,2]
C3174092
E
Hospitalization
Beschreibung

Hospitalization

Alias
UMLS CUI-1
C0019993
Number of Nights in Hospital (Day 1 until start of Protocol IIB-ASP+)
Beschreibung

Hospital nights

Datentyp

float

Maßeinheiten
  • nights
Alias
UMLS CUI [1]
C0420496
nights
Identification and Signature
Beschreibung

Identification and Signature

Alias
UMLS CUI-1
C0205396
UMLS CUI-3
C1519316
Date and signature of the doctor who calculated and created chemotherapy regimen
Beschreibung

Chemotherapy creator: signature

Datentyp

text

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1707531
UMLS CUI [2]
C1519316
Date and signature of the person who administered chemotherapy
Beschreibung

Chemotherapy administration: signature

Datentyp

text

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1533734
UMLS CUI [2]
C1519316
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Protocol IB-ASP+ AIEOP-BFM ALL 2009 NCT01117441

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Patient ID
Item
Stud.-Nr. (Pat.-ID)
text
C2348585 (UMLS CUI [1])
Patient birthday
Item
Patient date of birth
date
C0421451 (UMLS CUI [1])
Weight
Item
Body weight
float
C0005910 (UMLS CUI [1])
Height
Item
Body height
float
C0005890 (UMLS CUI [1])
Body surface
Item
Body surface
float
C0005902 (UMLS CUI [1])
Item Group
Chemotherapy Regimen
C0392920 (UMLS CUI-1)
Dexamethasone: administration form
Item
Dexamethasone administration form
text
C0011777 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
Dexamethasone: dosage
Item
Dexamethasone dosage 10 mg/mˆ2/d
float
C0011777 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Dexamethasone: date of administration
Item
Dexamethasone Date of administration
date
C0011777 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
VCR: administration form
Item
VCR administration form i.v.
boolean
C0042679 (UMLS CUI [1,1])
C1522726 (UMLS CUI [1,2])
VCR: dosage
Item
VCR dosage 1,5 mg/mˆ2/ED (max. 2 mg/ED)
float
C0042679 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
VCR: date of administration
Item
VCR Date of administration
date
C0042679 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
DOX: administration form
Item
Doxorubicin administration form p.i. (1h)
boolean
C0013089 (UMLS CUI [1,1])
C1827465 (UMLS CUI [1,2])
DOX: dosage
Item
Doxorubicin dosage 30 mg/mˆ2/ED
float
C0013089 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
DOX: date of administration
Item
Doxorubicin Date of administration
date
C0013089 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
MTX: administration form
Item
MTX administration form i.th
boolean
C0025677 (UMLS CUI [1,1])
C0677897 (UMLS CUI [1,2])
MTX: dosage
Item
MTX dosage (Age-dependent: 1 - < 2 y/o: 8 mg 2 - < 3y/o: 10 mg >= 3 y/o: 12 mg
float
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
MTX: date of administration
Item
MTX Date of administration (while MTX infusion)
date
C0025677 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
MTX and CNS status: date of administration
Item
If initial CNS status CNS3, MTX dose (i.th., on day 1 and 18): Date of administration
date
C0025677 (UMLS CUI [1,1])
C0449389 (UMLS CUI [1,2])
C2584899 (UMLS CUI [1,3])
PEG-L-ASP: administration form
Item
PEG-L-ASP administration form p.i. (2h)
boolean
C0071568 (UMLS CUI [1,1])
C1827465 (UMLS CUI [1,2])
PEG-L-ASP: dosage
Item
PEG-L-ASP dosage 2500 E/mˆ2/ED (ONCASPAR: 3750 E/ED)
float
C0071568 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
PEG-L-ASP: date of administration
Item
PEG-L-ASP (Next PEG-L-ASP dose: 14 days after dose of day 22)) Date of administration
date
C0071568 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
Item Group
PEG-L-ASP discontinuation
C0071568 (UMLS CUI-1)
C0457454 (UMLS CUI-2)
PEG-L-ASP discontinuation
Item
Discontinuation of PEG-L-ASP therapy in Protocol IIA-ASP+?
boolean
C0071568 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
Item
If discontinuation of PEG-L-ASP therapy, specify: Reason for discontinuation:
text
C0071568 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Reason for discontinuation of PEG-L-ASP therapy
Code List
If discontinuation of PEG-L-ASP therapy, specify: Reason for discontinuation:
CL Item
allergic reaction to PEG-L-ASP (allergic reaction to PEG-L-ASP)
CL Item
DVT or SVT (DVT or SVT)
CL Item
Pancreatitis (Pancreatitis)
CL Item
Insulin-dependent hyperglycaemia (Insulin-dependent hyperglycaemia)
CL Item
other medical reason (other medical reason)
CL Item
other non-medical reason (other non-medical reason)
Reason for discontinuation of PEG-L-ASP therapy: specification
Item
If discontinuation of PEG-L-ASP therapy, specify: Reason for discontinuation: If other medical or non-medical reason, specify:
text
C0071568 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
Item
If discontinuation of PEG-L-ASP therapy, specify: PEG-L-ASP: date of last administration
text
C0071568 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,3])
PEG-L-ASP: date of last administration
Code List
If discontinuation of PEG-L-ASP therapy, specify: PEG-L-ASP: date of last administration
CL Item
Protocol Day 8 (Protocol Day 8)
CL Item
Protocol Day 22 (Protocol Day 22)
Change to Erwinase
Item
Change to Erwinase?
boolean
C0580105 (UMLS CUI [1,1])
C0591457 (UMLS CUI [1,2])
Erwinase: date of first administration
Item
If change to Erwinase, specify: Erwinase: date of first administration
date
C0591457 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
C0205435 (UMLS CUI [1,3])
Erwinase: date of last administration
Item
If change to Erwinase, specify: Erwinase: date of last administration
date
C0591457 (UMLS CUI [1,1])
C2584899 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,3])
Numbers of Erwinase doses
Item
If change to Erwinase, specify: Numbers of Erwinase doses
float
C0591457 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Erwinase dose
Item
If change to Erwinase, specify: Erwinase dose
float
C0591457 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
Item Group
Hospitalization
C0019993 (UMLS CUI-1)
Hospital nights
Item
Number of Nights in Hospital (Day 1 until start of Protocol IIB-ASP+)
float
C0420496 (UMLS CUI [1])
Item Group
Identification and Signature
C0205396 (UMLS CUI-1)
C1519316 (UMLS CUI-3)
Chemotherapy creator: signature
Item
Date and signature of the doctor who calculated and created chemotherapy regimen
text
C0392920 (UMLS CUI [1,1])
C1707531 (UMLS CUI [1,2])
C1519316 (UMLS CUI [2])
Chemotherapy administration: signature
Item
Date and signature of the person who administered chemotherapy
text
C0392920 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
C1519316 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video